9.3 Avoidable Day Tracking, Barrier Resolution, and Complex Discharges

Avoidable Day Tracking, Barrier Resolution, and Complex Discharges

In acute care health delivery systems, hospital throughput and patient flow are primary determinants of clinical quality, operational efficiency, and financial viability. When an inpatient remains in an acute care bed beyond the point of medical necessity, the hospital incurs direct uncompensated operating expenses, bed availability for emergency and surgical admissions is constricted, and the patient is subjected to unnecessary risks of hospital-acquired complications (nosocomial infections, venous thromboembolism, functional deconditioning, and delirium). Case managers serve as the frontline leaders responsible for identifying, documenting, and resolving avoidable delays while orchestrating safe transitions for the most vulnerable and clinically complex patient populations.

---

Principles of Avoidable Day Tracking

An avoidable day (also termed an excess day or delay day) is defined as any 24-hour inpatient day during which a patient occupies an acute care bed but does not meet established clinical criteria for acute level of care (i.e., InterQual or MCG criteria for severity of illness and intensity of service), or where care progression was halted due to preventable internal or external operational bottlenecks.

Benchmarking Against GMLOS and Financial Impact

In the inpatient prospective payment system (IPPS), Medicare and most commercial payers reimburse hospitals on a per-discharge basis determined by the patient's assigned Medicare Severity Diagnosis-Related Group (MS-DRG). CMS establishes two length-of-stay benchmarks for every MS-DRG:

• Arithmetic Mean Length of Stay (AMLOS): The simple mathematical average of all stay lengths within that DRG.
• Geometric Mean Length of Stay (GMLOS): The geometric mean, which minimizes the distortion of extreme statistical outliers. CMS uses GMLOS to calculate per diem payments under its transfer policies; outlier payments depend on cost thresholds, not length of stay.

Avoidable Day Dynamics:
┌───────────────────────────────────────────────────────────────┐
│ Acute Clinical Care Progression (Meets Inpatient Criteria)    │
├──────────────────────────────────┬────────────────────────────┤
│ Inpatient Days 1 to 4: Medically  │ Inpatient Days 5 to 8:     │
│ Necessary (GMLOS = 4.2 Days)     │ AVOIDABLE DAYS (Excess LOS)│
└──────────────────────────────────┴────────────────────────────┘
                                   ▲
                                   │
                     Discharge Barrier Arises:
                     - Payer Prior Auth Delay (2 Days)
                     - SNF Bed Shortage (2 Days)

When a patient's acute stay exceeds the GMLOS due to non-clinical delays, the hospital receives zero additional reimbursement (unless the stay reaches high-cost outlier thresholds, which cover only a fraction of marginal costs). Direct variable costs—such as nursing labor, pharmaceuticals, diagnostic maintenance, food, and overhead—accumulate daily, transforming a financially viable admission into an institutional operating loss.

Calculating Avoidable Day Metrics

Case management leadership tracks avoidable day metrics to drive institutional Plan-Do-Study-Act (PDSA) quality improvement:

• Avoidable Day Rate: $\text{Avoidable Day Rate (\%)} = \left(\frac{\text{Total Avoidable Days}}{\text{Total Inpatient Days}}\right) \times 100$
• Opportunity Cost: Calculating the lost net revenue from elective surgical or transfer admissions turned away due to acute bed unavailability caused by avoidable delay days.

---

Taxonomy of Inpatient Barriers: Internal vs. External Delays

To remediate throughput delays systematically, case managers categorize avoidable days into a standardized taxonomy dividing barriers into internal (hospital-controlled) and external (systemic/payer-controlled) factors.

---

High-Complexity Clinical Discharge Scenarios

Case managers frequently encounter high-complexity clinical scenarios where standard discharge pathways are blocked by clinical, financial, or legal boundaries. Mastering these scenarios is essential for the ACM-RN.

1. Maintenance Dialysis for Undocumented or Unfunded Patients

• The Clinical Dilemma: End-stage kidney disease (ESKD) patients who are undocumented immigrants or completely uninsured do not qualify for standard Medicare Part A/B or traditional state Medicaid programs. Under the Emergency Medical Treatment and Labor Act (EMTALA), acute care hospitals must provide emergency stabilization (including emergency dialysis) when life-threatening hyperkalemia, pulmonary edema, or uremic encephalopathy occurs, but EMTALA does not mandate or fund scheduled maintenance outpatient dialysis.
• The Inpatient Trap: Without maintenance dialysis, patients return to the emergency department weekly in severe metabolic crisis, resulting in repeated ICU admissions and astronomical uncompensated hospital costs.
• Case Management Solutions:
  • Navigating state-specific Emergency Medicaid or state programs: Several states (for example, California, New York, and Colorado) pay for scheduled outpatient dialysis for people who qualify only for emergency coverage.
  • Establishing hospital-subsidized outpatient dialysis arrangements: Some health systems contract with outpatient dialysis providers for scheduled treatment, which is usually far less costly and safer than repeated emergency admissions for crisis dialysis.
  • Enrolling patients in charitable kidney foundations (e.g., American Kidney Fund) or safety-net community clinic networks.

2. Prolonged IV Antimicrobial Therapy with Active Substance Use Disorder (SUD)

• The Clinical Dilemma: Patients with active injection drug use (IDU) presenting with infective endocarditis, osteomyelitis, or epidural abscess require 4 to 6 weeks of intravenous antibiotics. Hospital discharge with a Peripherally Inserted Central Catheter (PICC) is frequently deemed an unacceptable safety risk by clinicians due to the hazard of line tampering, injection of illicit substances into vascular access, and lethal overdose. Concurrently, many SNFs decline patients with active substance use or those receiving medications for opioid use disorder (MOUD) such as methadone or buprenorphine, although the U.S. Department of Justice has said that refusing patients because they take MOUD can violate the Americans with Disabilities Act.
• Case Management Solutions:
  • Long-Acting Lipoglycopeptide Therapy: Agents such as dalbavancin or oritavancin are given as one infusion or two infusions a week apart and remain active for weeks. Infectious disease specialists use them, sometimes off-label, to complete therapy for infections such as osteomyelitis, which allows PICC removal and discharge without daily vascular access.
  • Oral Step-Down Therapy: Collaborating with Infectious Disease specialists to transition from IV therapy to high-bioavailability oral regimens (e.g., fluoroquinolones, linezolid, trimethoprim-sulfamethoxazole) supported by recent randomized trials (e.g., the POET trial for endocarditis and the OVIVA trial for osteomyelitis).
  • Medical Respite and Harm-Reduction Partnerships: Partnering with specialized medical respite facilities that combine addiction medicine, supervised MAT administration, and monitored infusion therapy.

3. Negative-Pressure Wound Therapy (Wound VAC) at Discharge

• Coverage Barriers: Payer coverage for home Wound VAC therapy (under Medicare Part B DME) requires strict documentation: wound measurements (length, width, depth), photographic progression, failure of traditional moist wound dressings for at least 30 days, and surgical debridement documentation. Coverage will be immediately denied if active untreated osteomyelitis, un-cleared necrotic tissue, or untreated wound infection is present.
• Execution Protocol: The case manager verifies the signed standard written order and supporting documentation (Medicare no longer uses CMNs), confirms delivery of the device and canisters, and arranges home health nursing for dressing changes, often three times weekly.

4. Adult Protective Services (APS) Holds

When hospitalization uncovers physical abuse, financial exploitation, or severe self-neglect involving an older or vulnerable adult, healthcare professionals are mandated reporters under state law. Case managers must notify Adult Protective Services immediately. If APS finds the home hazardous or the caregiver abusive, it may seek emergency protective services or a court order where state law allows. The team should not discharge the patient back to an unsafe setting while a safe plan, surrogate, or guardianship is arranged.

---

Resolving Discharge Disputes and Patient Reluctance

When a medically stable patient or family refuses discharge, case managers must deploy a structured conflict escalation pathway rather than resorting to punitive measures:

Discharge Dispute Escalation Pathway:
┌────────────────────────────────────────────────────────┐
│ Level 1: Bedside Nurse & Case Manager Dialogue         │
│ Assess root fears, financial worries, caregiver strain │
└──────────────────────────┬─────────────────────────────┘
                           │ [If Unresolved]
                           ▼
┌────────────────────────────────────────────────────────┐
│ Level 2: Interprofessional Family Conference           │
│ MD, CM, MSW, PT present unified plan & educate on risks│
└──────────────────────────┬─────────────────────────────┘
                           │ [If Unresolved]
                           ▼
┌────────────────────────────────────────────────────────┐
│ Level 3: Physician Advisor Engagement                  │
│ Peer-to-peer discussion with family; clinical review   │
└──────────────────────────┬─────────────────────────────┘
                           │ [If Intractable Dispute]
                           ▼
┌────────────────────────────────────────────────────────┐
│ Level 4: Clinical Ethics Committee Consultation        │
│ Resolve autonomy vs. beneficence / justice dilemmas    │
└──────────────────────────┬─────────────────────────────┘
                           │ [Legal & Administrative Action]
                           ▼
┌────────────────────────────────────────────────────────┐
│ Level 5: Issuance of Statutory Noncoverage Notice      │
│ Issue HINN 12; establish patient financial liability   │
└────────────────────────────────────────────────────────┘

---

Against Medical Advice (AMA) Protocol

Discharge Against Medical Advice (AMA) occurs when a patient chooses to leave the hospital before the treating medical team deems it clinically safe. AMA discharges present severe legal, ethical, and clinical challenges for health system case managers.

1. Clinical Decisional Capacity: The Absolute Prerequisite

A patient has the fundamental common-law and constitutional right of bodily autonomy—including the right to refuse recommended life-sustaining medical treatment—only if they possess clinical decisional capacity at the exact time of refusal.

Decisional capacity is a clinical determination made by the attending physician (not a legal determination of competence made by a judge). To possess capacity to leave AMA, the patient must demonstrate Four Functional Criteria:

1. Understanding: The ability to comprehend the diagnosis, proposed treatment, alternatives, and risks of leaving.
2. Appreciation: The ability to apply that understanding to their own personal situation (acknowledging that they personally face these risks).
3. Reasoning: The ability to process information logically and weigh the risks and benefits against personal values.
4. Communication of a Choice: The ability to clearly and consistently articulate an unambiguous decision.

2. Debunking the Third-Party Payer Refusal Myth

A pervasive and dangerous myth in clinical medicine is that insurance companies (Medicare, Medicaid, or commercial payers) will automatically refuse to pay for a hospital stay if the patient leaves Against Medical Advice. Clinicians frequently use this threat to coerce patients into staying.

Research has found no evidence that insurers deny hospital claims simply because a patient left AMA; a widely cited 2012 study of AMA discharges found no such denials. Hospitals are reimbursed for all medically necessary services rendered up to the moment of departure. Telling a patient their insurance will not cover their stay is a false statement, violates medical ethics, and exposes the clinical team to liability for coercive practices.

3. Safe Transition and Harm-Reduction Mandate for AMA Discharges

Leaving AMA does not terminate the hospital's ethical duty of care, nor does it constitute clinician abandonment. If a patient with decisional capacity insists on leaving, the case manager and medical team must execute a harm-reduction discharge protocol:

• Thorough Informed Refusal Discussion: Clearly explain specific clinical risks, explicitly including permanent disability, sepsis, amputation, or death. Document these specific discussions in the EHR.
• Execution of the AMA Form: Ask the patient to sign the hospital's AMA form. If the patient refuses, document the refusal according to hospital policy (often with a witness).
• Provide Prescriptions and Medical Supplies: Provide the patient with oral antibiotic prescriptions, discharge medications, wound dressings, and instruction sheets. Withholding prescriptions or supplies as punishment for leaving AMA falls below the standard of care.
• Facilitate Follow-Up: Provide telephone numbers for outpatient clinics and emergency services.
• The Open-Door Statement: Explicitly inform the patient in person and in writing that they are welcome to return to the emergency department or hospital at any time if their condition worsens, without judgment or penalty.